Literature DB >> 14222674

THE RELATIONSHIP OF DOSAGE SCHEDULE TO THE BLOOD LEVEL OF QUINIDINE, USING ALL AVAILABLE QUINIDINE PREPARATIONS.

W M GOLDBERG, S G CHAKRABARTI.   

Abstract

Blood quinidine levels obtained by single and multiple dosage schedules of all available quinidine preparations were ascertained. A maintenance blood level of 4 to 7 mg./l. of quinidine was considered a desirable range to prevent recurrence of auricular fibrillation in patients previously converted to sinus rhythm. Quinidine sulfate, quinidine gluconate, dihydroquinidine gluconate and quinidine polygalacturonate were given in dosage schedules of one tablet (equivalent to 200 mg. quinidine) every eight hours for four days, then two tablets every eight hours for three days. Blood quinidine levels were determined the same time each day. Schedules of two tablets of quinidine sulfate or quinidine gluconate every eight hours resulted in blood levels between 4 and 7 mg./l. Similar dosage schedules of the other preparations did not produce levels of this order, nor did quinidine polygalacturonate administered in a 12-hourly schedule. Serious respiratory arrest occurred in one case following quinidine sulfate. No other toxic reactions were noted in this study.

Entities:  

Keywords:  AURICULAR FIBRILLATION; BLOOD; CLINICAL RESEARCH; DOSAGE FORMS; DRUG THERAPY; QUINIDINE

Mesh:

Substances:

Year:  1964        PMID: 14222674      PMCID: PMC1928075     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN: 0008-4409            Impact factor:   8.262


  12 in total

1.  The management of cardiac arrhythmias with quinidine polygalacturonate.

Authors:  R TRICOT; P NOGRETTE
Journal:  Am J Med Sci       Date:  1962-02       Impact factor: 2.378

2.  New method for terminating cardiac arrhythmias. Use of synchronized capacitor discharge.

Authors:  B LOWN; R AMARASINGHAM; J NEUMAN
Journal:  JAMA       Date:  1962-11-03       Impact factor: 56.272

3.  Evaluation of a new quinidine compound: a comparative study.

Authors:  H H POTE
Journal:  Angiology       Date:  1961-07       Impact factor: 3.619

4.  A clinical evaluation of quinidine polygalacturonate.

Authors:  G SCHWARTZ
Journal:  Angiology       Date:  1959-04       Impact factor: 3.619

5.  Study of a long-acting quinidine preparation: experience in normal subjects and in patients with myocardial abnormality.

Authors:  S BELLET; D FINKELSTEIN; H GILMORE
Journal:  AMA Arch Intern Med       Date:  1957-11

6.  Factors influencing conversion of chronic atrial fibrillation with special reference to serum quinidine concentration.

Authors:  R E BALL; M SOKOLOW
Journal:  Circulation       Date:  1956-10       Impact factor: 29.690

7.  The basis of quinidine therapy.

Authors:  W D LOVE
Journal:  Am J Med Sci       Date:  1955-01       Impact factor: 2.378

8.  Concentrations of quinidine in blood following delayed-absorption tablets.

Authors:  E M L DITLEFSEN
Journal:  Acta Med Scand       Date:  1954

9.  Studies of plasma quinidine content. III. The value of delayed absorptive coated tablets in oral quinidine therapy.

Authors:  J J SAMPSON; H FOREMAN; B C SOLOMON
Journal:  Circulation       Date:  1952-04       Impact factor: 29.690

10.  Experiences with the photofluorometric determination of quinidine in blood.

Authors:  A L EDGAR; M SOKOLOW
Journal:  J Lab Clin Med       Date:  1950-09
View more
  5 in total

Review 1.  Critical compilation of terminal half-lives, percent excreted unchanged, and changes of half-life in renal and hepatic dysfunction for studies in humans with references.

Authors:  L A Pagliaro; L Z Benet
Journal:  J Pharmacokinet Biopharm       Date:  1975-10

2.  Comparison of quinidine plasma concentration curves following oral administration of some short- and long-acting formulations.

Authors:  G M Frigo; E Perucca; M Teggia-Droghi; G Gatti; A Mussini; J Salerno
Journal:  Br J Clin Pharmacol       Date:  1977-08       Impact factor: 4.335

3.  Divergence in pharmacokinetic parameters of quinidine obtained by specific and nonspecific assay methods.

Authors:  T W Guentert; R A Upton; N H Holford; S Riegelman
Journal:  J Pharmacokinet Biopharm       Date:  1979-06

4.  Quinidine dosage, with special reference to an oral loading dose schedule.

Authors:  P Collste; R Nordlander
Journal:  Br J Clin Pharmacol       Date:  1979-03       Impact factor: 4.335

5.  Absorption of quinidine and dihydroquinidine in humans.

Authors:  D M Hailey; A R Lea; D M Coles; P E Heaume; W J Smith
Journal:  Eur J Clin Pharmacol       Date:  1981       Impact factor: 2.953

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.